Selway Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Selway Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$874K	Hold	14,331	–	–	0.36%	52
2024 Q4	$811K	Sell	14,331 -1,500	-9%	-$83.8K	0.32%	54
2024 Q3	$819K	Sell	15,831 -21,100	-57%	-$990K	0.32%	54
2024 Q2	$1.53M	Sell	36,931 -3,035	-8%	-$136K	0.63%	45
2024 Q1	$2.17M	Sell	39,966 -1,100	-3%	-$56K	0.87%	37
2023 Q4	$2.11M	Sell	41,066 -5,468	-12%	-$287K	0.89%	36
2023 Q3	$2.7M	Sell	46,534 -2,780	-6%	-$170K	1.24%	28
2023 Q2	$3.15M	Buy	49,314 +60	+0.1%	+$4.02K	1.38%	27
2023 Q1	$3.41M	Buy	49,254 +4,000	+9%	+$282K	1.64%	23
2022 Q4	$3.26M	Sell	45,254 -585	-1%	-$44.1K	1.72%	22
2022 Q3	$3.26M	Sell	45,839 -131	-0.3%	-$9.5K	1.9%	17
2022 Q2	$3.54M	Buy	45,970 +500	+1%	+$38.1K	1.96%	15
2022 Q1	$3.32M	Sell	45,470 -3,300	-7%	-$222K	1.61%	21
2021 Q4	$3.04M	Sell	48,770 -200	-0.4%	-$11.7K	1.44%	25
2021 Q3	$2.9M	Buy	48,970 +275	+0.6%	+$18.1K	1.58%	23
2021 Q2	$3.25M	Buy	48,695 +2,050	+4%	+$134K	1.74%	20
2021 Q1	$2.94M	Buy	46,645 +4,075	+10%	+$254K	1.71%	17
2020 Q4	$2.64M	Buy	42,570 +800	+2%	+$49.2K	1.61%	20
2020 Q3	$2.52M	Buy	41,770 +9,300	+29%	+$560K	1.78%	20
2020 Q2	$1.91M	Buy	32,470 +125	+0.4%	+$7.48K	1.52%	24
2020 Q1	$1.8M	Buy	32,345 +850	+3%	+$52K	1.74%	21
2019 Q4	$2.02M	Buy	+31,495	New	+$1.8M	1.39%	24

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Selway Asset Management's BMY Position: Q1 2025 in Review

Selway Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2025 at 14,331 shares worth $874K. The position accounts for 0.36% of the portfolio, ranked #52.

Selway Asset Management first reported a position in BMY in Q4 2019 and has held it in 22 quarters since. The position peaked at $3.54M in Q2 2022. 2,476 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Selway Asset Management held 14,331 shares of Bristol-Myers Squibb worth $874K as of Q1 2025.
Selway Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2025.
Bristol-Myers Squibb made up 0.36% of Selway Asset Management's portfolio in Q1 2025, its #52 holding.
Selway Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 22 quarters since.
Selway Asset Management's Bristol-Myers Squibb position peaked at $3.54M in Q2 2022.
2,476 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Selway Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.